Form: POS AM

Post-effective amendment to a registration statement that is not immediately effective upon filing

September 30, 1998

EXHIBIT 24.3 CONSENT OF RICHARD EISNER

Published on September 30, 1998




EXHIBIT 24.3



INDEPENDENT AUDITORS' CONSENT

We consent to the incorporation by reference in this Registration Statement
on Form S-3 (Post-Effective Amendment No. 2 to Form SB-2) of Cytoclonal
Pharmaceutics Inc. of our report, dated February 6, 1998, (with respect to
Note K[2], April 13, 1998) on our audits of the financial statements of
Cytoclonal Pharmaceutics Inc. as of December 31, 1997 and for each of the years
in the two-year period ended December 31, 1997 and for the period from
September 11, 1991 (inception) through December 31, 1997, included in the
Company's Annual Report on Form 10-KSB for the year ended December 31, 1997.
We also consent to the reference of our firm under the caption "Experts"
included in the Prospectus.


RICHARD A. EISNER & COMPANY, LLP
- ---------------------------------
Richard A. Eisner & Company, LLP

New York, New York
September 25, 1998